A twice-yearly injection could revolutionize HIV prevention. But who gets access raises bigger questions about public money, pharmaceutical power, drug prices and shrinking global health funding. Al Jazeera’s Mikail Malik looks at the fight for access. Published September 30, 2026 September 30, 2026 Share It’s “the closest thing to an HIV vaccine,” but who gets access? on social networksshare-nodesSharegoogleAdd Al Jazeera on Googleinfo
